WallStreetZen

NYSE: ABC
Amerisourcebergen Corp Stock Forecast, Predictions & Price Target

Analyst price target for ABC

Based on 6 analysts offering 12 month price targets for Amerisourcebergen Corp.
Min Forecast
$114.00-0.07%
Avg Forecast
$138.83+21.7%
Max Forecast
$153.00+34.12%

Should I buy or sell ABC stock?

Based on 6 analysts offering ratings for Amerisourcebergen Corp.
Buy
Strong Buy
1 analysts 16.67%
Buy
2 analysts 33.33%
Hold
3 analysts 50%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

ABC stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Deutsche Bank
Top 16%
85
HoldMaintains$153.00+34.12%2021-11-12
Credit Suisse
Bottom 3%
3
BuyMaintains$145.00+27.10%2021-11-08
Anonymous
Barclays
HoldMaintains$135.00+18.34%2021-11-05
Morgan Stanley
Top 5%
96
Strong BuyMaintains$141.00+23.60%2021-08-31
Barclays
Top 31%
70
HoldMaintains$130.00+13.96%2021-05-06
Mizuho
Top 14%
87
HoldMaintains$114.00-0.07%2021-02-09
Cowen & Co.
Bottom 45%
45
BuyMaintains$150.00+31.49%2021-02-08

1 of 1

Forecast return on equity

Is ABC forecast to generate an efficient return?
Company
1,069.77%
Industry
27.79%
Market
46.73%
ABC's Return on Equity is forecast to be high in 3 years (1,069.77%); analysts are confident in the firm's ability to efficiently generate return on equity
Forecast

Forecast return on assets

Is ABC forecast to generate an efficient return on assets?
Company
4.17%
Industry
10.95%
ABC is forecast to generate lower Return on Assets (4.17%) than the US Healthcare industry average (10.95%)
Forecast

ABC earnings per share forecast

What is ABC's earnings per share in the next 2 years based on estimates from 6 analysts?
Avg 1 year Forecast
$10.62+41.98%
Avg 2 year Forecast
$11.48+53.48%
ABC's earnings are forecast to grow at an exceptional rate of 23.89% per year
Forecast

ABC revenue forecast

What is ABC's revenue in the next 2 years based on estimates from 2 analysts?
Avg 1 year Forecast
$236.7B+10.61%
Avg 2 year Forecast
$248.5B+16.14%
ABC's revenue is forecast to grow at a rate of 7.77% per year, which is not exceptional
Forecast

ABC earnings growth forecast

How is ABC forecast to perform vs Healthcare companies and vs the US market?
Company
23.89%
Industry
22.78%
Market
17.66%
ABC's earnings are forecast to grow faster (23.89% per year) than the US Healthcare industry average (22.78%)
Forecast
ABC's earnings are forecast to grow faster (23.89% per year) than the US market average (17.66%)
Forecast
ABC's earnings are forecast to grow faster (23.89% per year) than the risk-free savings rate (1.4%)
Forecast

ABC revenue growth forecast

How is ABC forecast to perform vs Healthcare companies and vs the US market?
Company
7.77%
Industry
17.7%
Market
10.77%
ABC's revenues are forecast to grow slower (7.77% per year) than the US Healthcare industry average (17.7%)
Forecast
ABC's revenues are forecast to grow slower (7.77% per year) than the US market average (10.77%)
Forecast

Amerisourcebergen Corp Stock Forecast FAQ

Is Amerisourcebergen Corp Stock a good buy in 2021, according to Wall Street analysts?

The consensus among 6 Wall Street analysts covering (NYSE: ABC) stock is to Buy ABC stock.

Out of 6 analysts, 1 (16.67%) are recommending ABC as a Strong Buy, 2 (33.33%) are recommending ABC as a Buy, 3 (50%) are recommending ABC as a Hold, 0 (0%) are recommending ABC as a Sell, and 0 (0%) are recommending ABC as a Strong Sell.

What is ABC's earnings growth forecast for 2022-2023?

(NYSE: ABC) Amerisourcebergen Corp's forecast annual earnings growth rate of 23.89% is forecast to beat the US Healthcare industry's average forecast earnings growth rate of 22.78%, and and it is also forecast to beat the US market's average forecast earnings growth rate of 17.66%.

Amerisourcebergen Corp's earnings in 2021 is $1,539,932,000.On average, 6 Wall Street analysts forecast ABC's earnings for 2022 to be $2,210,376,294, with the lowest ABC earnings forecast at $2,164,586,954, and the highest ABC earnings forecast at $2,222,864,295.

In 2023, ABC is forecast to generate $2,389,370,984 in earnings, with the lowest earnings forecast at $2,345,662,978 and the highest earnings forecast at $2,426,834,989.

What is ABC's revenue growth forecast for 2022-2023?

(NYSE: ABC) Amerisourcebergen Corp's forecast annual revenue growth rate of 7.77% is not forecast to beat the US Healthcare industry's average forecast revenue growth rate of 17.7%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.77%.

Amerisourcebergen Corp's revenue in 2021 is $213,988,843,000.On average, 2 Wall Street analysts forecast ABC's revenue for 2022 to be $49,262,870,837,728, with the lowest ABC revenue forecast at $49,247,745,786,384, and the highest ABC revenue forecast at $49,277,995,889,072.

In 2023, ABC is forecast to generate $51,725,811,345,521 in revenue, with the lowest revenue forecast at $51,389,671,180,439 and the highest revenue forecast at $51,914,227,608,833.

What is ABC's forecast return on assets (ROA) for 2022-2023?

(NYSE: ABC) forecast ROA is 4.17%, which is lower than the forecast US Healthcare industry average of 10.95%.

What is ABC's Price Target?

According to 6 Wall Street analysts that have issued a 1 year ABC price target, the average ABC price target is $138.83, with the highest ABC stock price forecast at $153.00 and the lowest ABC stock price forecast at $114.00.

On average, Wall Street analysts predict that Amerisourcebergen Corp's share price could stay at $138.83 by Nov 12, 2022. The average Amerisourcebergen Corp stock price prediction forecasts a potential downside of N/A from the current ABC share price of $114.08.

What is ABC's Earnings Per Share (EPS) forecast for 2022-2023?

(NYSE: ABC) Amerisourcebergen Corp's current Earnings Per Share (EPS) is $7.48. On average, analysts forecast that ABC's EPS will be $10.62 for 2022, with the lowest EPS forecast at $10.40, and the highest EPS forecast at $10.68. In 2023, ABC's EPS is forecast to hit $11.48 (min: $11.27, max: $11.66).

What is ABC's forecast return on equity (ROE) for 2022-2023?

(NYSE: ABC) forecast ROE is 1,069.77%, which is considered strong.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.